SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

HC Wainwright & Co. Reiterates Buy on Calithera Biosciences, Raises Price Target to $9.5

HC Wainwright & Co. reiterates Calithera Biosciences (NASDAQ:CALA) with a Buy and raises the price target from $7 to $9.5.

Benzinga · 05/08/2020 11:16

HC Wainwright & Co. reiterates Calithera Biosciences (NASDAQ:CALA) with a Buy and raises the price target from $7 to $9.5.